Grass Mix

Grass mix allergens, which consist of pollen from multiple grass species, such as timothy, ryegrass, and Bermuda grass, are a common cause of seasonal allergic rhinitis. 

Due to high cross-reactivity among grass pollens—particularly in group 1 and 5 allergens—these mixes are widely used in allergy testing and immunotherapy to identify and manage grass pollen sensitization.

Grass Mix: A Source of Allergens

Grass mix refers to a combination of pollen allergens from several grass species, commonly used in allergy testing and immunotherapy. These species typically include:

• Timothy grass (Phleum pratense)
• Ryegrass (Lolium perenne)
• Kentucky bluegrass (Poa pratensis)
• Bermuda grass (Cynodon dactylon)
• Orchard grass (Dactylis glomerata)
• Fescue, Bahia, and others

These grasses release large amounts of wind-borne pollen during the spring and summer. Because many grasses share structurally similar allergenic proteins—especially group 1 and 5 allergens—patients often react to multiple grass types, a phenomenon known as IgE cross-reactivity.

When is Grass Mix Allergy Testing Relevant?

Testing for grass mix allergy is recommended when patients present with seasonal allergic symptoms, particularly in the late spring or early summer. These may include:

• Nasal symptoms: Sneezing, runny or congested nose, postnasal drip
• Ocular symptoms: Itchy, red, or watery eyes
• Respiratory symptoms: Coughing, wheezing, or asthma flares
• Oropharyngeal symptoms: Itchy throat or ears

Allergy testing also aids in differentiating grass pollen allergy from reactions to tree, weed, or indoor allergens and helps guide immunotherapy decisions.

Cross-Reactivity and Pollen-Food Allergy Syndrome (PFAS)

Pollen-Food Allergy Syndrome (PFAS), also known as oral allergy syndrome, occurs when structurally similar proteins in grass pollen—particularly from timothy or orchard grass—cross-react with proteins in certain raw fruits and vegetables. 

This can lead to localized allergic symptoms, such as itching or swelling of the mouth, lips, and throat, especially after eating foods like cantaloupe, tomato, or watermelon.

Testing for Grass Mix Allergies

Grass Mix allergies may be assessed in the following ways:

Skin Prick Testing

Skin prick testing is a common and reliable method for diagnosing Grass Mix allergies. 

During this test, a small amount of Grass Mix allergen extract is placed on the skin, usually on the forearm or back, and gently pricked or scratched into the skin. A positive reaction typically appears within 15-20 minutes, indicated by a raised, red, itchy bump (wheal).

Limitations of Skin Prick Testing

Skin prick testing is not recommended if the patient has recently used antihistamines (1 week), H2 blockers (48 hours), tricyclic antidepressants (2 weeks), or omalizumab (6 months). 

It should also be deferred within 30 days of an anaphylactic episode due to risk of false negatives.

Serum Testing

Serum testing involves measuring specific immunoglobulin E (IgE) antibodies to Grass Mix in the patient's blood. This method is particularly useful for patients who cannot undergo skin testing due to skin conditions, medication use, or potential risk of severe reactions. 

Results typically take a few days to become available.

Limitations of Serum Testing

Serum IgE testing is not affected by antihistamines or recent allergic reactions. However, high IgE levels do not always predict reaction severity and may reflect chronic allergic conditions. 

False positives are possible, so results should always be interpreted alongside the patient’s history and physical exam. 

Importantly, serum testing does not measure mast cell-bound IgE, which is central to allergic reactions.

Intradermal Testing

Intradermal testing is a more sensitive but less commonly used method for evaluating grass mix allergies. This test involves injecting a small amount of allergen extract just beneath the skin’s surface to observe for a local reaction. 

While intradermal testing can detect allergic sensitization when skin prick tests are negative but clinical suspicion remains high, it carries a higher risk of systemic reactions such as anaphylaxis due to the use of higher allergen concentrations.

According to current guidelines, intradermal testing for airborne allergens like grass pollens is typically reserved for special cases—particularly when a patient's history strongly suggests grass pollen allergy but both skin prick and serum IgE tests are negative or inconclusive. 

It should only be performed in a controlled setting by trained professionals with appropriate safety measures in place.

Given its increased sensitivity and risk profile, intradermal testing is not recommended as a first-line diagnostic tool for grass mix allergy. It should be interpreted cautiously in the context of the patient’s clinical history.

What Do Positive Results on a Grass Mix Allergy Test Mean?

A positive skin prick test or serum-specific IgE test to grass mix indicates sensitization to one or more grass pollen allergens. This implies a high likelihood of allergic symptoms upon exposure. However, the clinical relevance must be confirmed by symptom history and timing (e.g., springtime rhinitis).

Most temperate-region patients show reactivity to group 1 (Phl p 1) and group 5 (Phl p 5) allergens, which are widely cross-reactive.

Pan-allergens (e.g., Phl p 4, Phl p 12) may cause positive results but have low clinical relevance.

What Do Negative Results on a Grass Mix Allergy Test Mean?

A negative test makes grass pollen allergy less likely but does not rule it out entirely. Reasons for false negatives include:

• Testing during off-season or under antihistamine use
• Sensitization to species-specific allergens not represented in the test panel
• Technical variability in natural extract quality

If symptoms persist, component-resolved diagnostics (e.g., IgE to Phl p 1, Phl p 5) may offer greater sensitivity.

Grass Mix and Immunotherapy

Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) using standardized grass pollen extracts are the only disease-modifying treatments for grass pollen allergy.

• In temperate regions, timothy grass extract alone is often sufficient due to extensive cross-reactivity among Pooideae species.
• Mixed grass extracts do not show superior efficacy over single-species extracts in clinical trials.
• Recombinant allergen vaccines (e.g., Phl p 1, 2, 5, 6) are emerging options, offering consistency and tailored immune responses.

A broader allergen panel or customized immunotherapy may be necessary for patients in subtropical climates, where grasses like Bermuda or Bahia lack certain major allergens.

Key Clinical Points

Grass pollen allergy is common and can be severe, especially in combination with asthma.

Cross-reactivity among temperate grasses supports the use of timothy-based testing and therapy in most cases.

False positives can result from IgE to cross-reactive carbohydrate determinants (CCDs) or pan-allergens, which are not clinically significant.

Consider recombinant or component-resolved diagnostics to refine diagnosis and guide treatment.

Monitor pollen forecasts and initiate pre-season treatment as appropriate.

Order Allergen Testing

Click here to compare testing options and order testing for a variety of potential allergens.